Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Table 3 Estimated impact and cost of different high risk strategies to prevent CVD in the Seychelles based on data in 2004

Treatment strategy	No. eligible to treat	Number of CVD events averted	Number needed to treat to avoid 1 CVD event	Total cost of medications (in US$ millions)	Cost of medications (US$) to avert 1 CVD event
BP ≥140/90 mmHg	44′899	127	354	1.84	14′534
Total cholesterol ≥6.2 mmol/l	28′317	39	727	1.24	31′831
High BP or high cholesterol	59′741	157	379	3.89	24′678
Risk ≥10%	10′837	137	79	1.03	7′499
Risk ≥20%	5′114	92	56	0.49	5′291
Risk ≥20%, BP ≥160/100, TC ≥8.0	20′653	147	140	1.96	13′307
Current situation	37′667	103	366	2.45	23′789

ISSN: 2107-6952